Login Register
About Us
Invite People

Share 4Engineers with your friends and help them get started!

Emails
Enter multiple email addresses by separating it with a comma.
Advanced Search
Back
4Engineers

Lonza to divest Capsules & Health Ingredients business

This article was originally posted on Chemical Engineering Online.
View article ->
Summary
Lonza AG (Basel, Switzerland) has signed a definitive deal to divest its Capsules & Health Ingredients (CHI) business to Lone Star Funds for an enterprise value of CHF 2.3 billion (about USD 3 billion). Lonza will receive CHF 1.7 billion (about USD 2.2 billion) in upfront cash and retain a 40% stake in the business.

How do you think Lonza’s decision to keep a 40% stake will shape CHI’s strategy and performance under Lone Star’s ownership?

Lonza AG (Basel, Switzerland) has entered into a definitive agreement to divest its Capsules & Health Ingredients (CHI) business to Lone Star Funds (“Lone Star”) for an enterprise value of CHF 2.3 billion (USD 3 billion). Lonza will realize upfront cash proceeds of CHF 1.7 billion (USD 2.2 billion) and retain a 40% stake in […]

The post Lonza to divest Capsules & Health Ingredients business appeared first on Chemical Engineering.

Login to comment

Login

Related Conversations

Recent Conversations

Your Conversations

Report content
Reason Description